Key result
Circulating betatrophin levels are significantly elevated in women with gestational diabetes mellitus.
Why the study?
Are circulating betatrophin levels elevated in women with gestational diabetes mellitus compared to those with normal glucose tolerance?
Meta-Analysis
Are circulating betatrophin levels elevated in women with gestational diabetes mellitus compared to those with normal glucose tolerance?
Circulating betatrophin levels are significantly elevated in women with gestational diabetes mellitus, particularly in the third trimester and in those with BMI ≥ 28 kg/m2.
Answers are grounded in this paper and cite their sources.
Elevated betatrophin may aid GDM risk stratification in obese women; leaves open causal role and therapeutic utility.
OBJECTIVE: The association between circulating betatrophin levels and gestational diabetes mellitus (GDM) is controversial. The aim of our study was to systematically review available literature linking betatrophin to GDM for a comprehensive understanding of the relationship between circulating betatrophin levels and GDM in human. METHODS: PubMed, The Cochrane Library, Medline and CNKI were searched for studies published up to August 2016. Manual searches of references of the relevant original studies were conducted. Pooled estimates were measured using the fixed or random effect model. Overall effect was reported in a standard mean difference (SMD). All data were analyzed with Review Manager 5.3 and Stata 12.0. RESULTS: Of 25 references reviewed, 8 studies met our inclusion criteria and contributed to meta-analysis. All the studies were used to evaluate the relationship between betatrophin levels in blood and GDM. Betatrophin levels were significantly elevated in women with GDM compared with those without GDM (SMD = 1.05; 95% CI: 0.41-1.68, P = 0.001). This evidence was more consistent among women with betatrophin blood draw during the third trimester (SMD = 1.3, 95% CI: 1-1.61, P < 0.001) and for women BMI ≥ 28 kg/m2 (SMD = 1.53, 95% CI: 1.30-1.75, P < 0.001). CONCLUSIONS: The evidences from this meta-analysis indicated that the levels of circulating betatrophin were significantly elevated among women with GDM compared with women with normal glucose tolerance, especially with BMI ≥ 28 kg/m2 and in the third trimester.
No takes yet. Share an insight, caveat, or question.
Kong et al. (2017) conducted a meta-analysis in Gestational Diabetes Mellitus. Gestational diabetes mellitus vs. Normal glucose tolerance (without GDM) was evaluated on Circulating betatrophin levels (SMD 1.05, 95% CI 0.41-1.68, p=0.001). Circulating betatrophin levels were elevated in women with gestational diabetes mellitus compared to those without.
Synapse has enriched 10 related papers. Consider them for comparative context: